Long-term persistence in patients with osteoporosis receiving denosumab in routine practice: 36-month non-interventional, observational study

ConclusionThis study to our knowledge represents the longest continuous observational period providing data on denosumab persistence in a real-world setting. The total persistence noted is quite robust when compared to bisphosphonates and is within the upper range of prior published studies of denosumab with shorter observation periods.
Source: Osteoporosis International - Category: Orthopaedics Source Type: research